Mortality and cumulative exposure to antipsychotics, antidepressants, and benzodiazepines in patients with schizophrenia: An observational follow-up study

American Journal of Psychiatry

Volumn 173, Issue 6, 2016, Pages 600-606

  Tiihonen, Jari ^a   Mittendorfer Rutz, Ellenor ^a   Torniainen, Minna ^a   Alexanderson, Kristina ^a   Tanskanen, Antti ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CONTROLLED STUDY; DEMOGRAPHY; DOSE RESPONSE; DRUG EFFECT; DRUG EXPOSURE; DRUG MEGADOSE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; SCHIZOPHRENIA; SUICIDE; DRUG UTILIZATION; FACTUAL DATABASE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; STATISTICS AND NUMERICAL DATA; SWEDEN; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; DATABASES, FACTUAL; DRUG UTILIZATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SCHIZOPHRENIA; SWEDEN; YOUNG ADULT;

EID: 84973305090     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2015.15050618     Document Type: Article

References (20)

1. Gøtzsche PC: [Psychiatry astray]. Politiken, Jan 6, 2014 (http://politiken.dk/debat/kroniken/ECE2174657/psykiatri-paa-afveje/) (Danish)
2. Torniainen M, Mittendorfer-Rutz E, Tanskanen A, et al: Antipsychotic treatment and mortality in schizophrenia. Schizophr Bull 2015; 41: 656-663
3. Cullen BA, McGinty EE, Zhang Y, et al: Guideline-concordant antipsychotic use and mortality in schizophrenia. Schizophr Bull 2013; 39:1159-1168
4. Hennessy S, Bilker WB, Knauss JS, et al: Cardiac arrest and ventricular arrhythmia in patients taking antipsychotic drugs: cohort study using administrative data. BMJ 2002; 325:1070
5. Ballon J, Stroup TS: Polypharmacy for schizophrenia. Curr Opin Psychiatry 2013; 26:208-213
6. Tiihonen J, Suokas JT, Suvisaari JM, et al: Polypharmacy with antipsychotics, antidepressants, orbenzodiazepines and mortality in schizophrenia. Arch Gen Psychiatry 2012; 69:476-483
7. Baandrup L, Gasse C, Jensen VD, et al: Antipsychotic polypharmacy and risk of death from natural causesin patients with schizophrenia: a population-based nested case-controlstudy. J Clin Psychiatry 2010; 71:103-108
8. Fall K, Strömberg F, Rosell J, et al: Reliability of death certificates in prostate cancer patients. Scand J Urol Nephrol 2008; 42:352-357
9. Scherrer JF, Chrusciel T, Garfield LD, et al: Treatment-resistant and insufficiently treated depression and all-cause mortality following myocardial infarction. Br J Psychiatry 2012; 200:137-142
10. Sowden GL, Huffman JC: The impact of mental illness on cardiac outcomes: a review for the cardiologist. Int J Cardiol 2009; 132: 30-37
11. Garfield LD, Scherrer JF, Hauptman PJ, et al: Association of anxiety disorders and depression with incident heart failure. Psychosom Med 2014; 76:128-136
12. Kanwar A, Malik S, Prokop LJ, et al: The association between anxiety disorders and suicidal behaviors: a systematic review and metaanalysis. Depress Anxiety 2013; 30:917-929
13. Hawton K, Casañas I Comabella C, Haw C, et al: Risk factors for suicide in individuals with depression: a systematic review. J Affect Disord 2013; 147:17-28
14. Andrade C, Kumar CB, Surya S: Cardiovascular mechanisms of SSRI drugs and their benefits and risksin ischemic heart disease and heart failure. Int Clin Psychopharmacol 2013; 28:145-155
15. Brunette MF, Noordsy DL, Xie H, et al: Benzodiazepine use and abuse among patients with severe mental illness and co-occurring substance use disorders. Psychiatr Serv 2003; 54:1395-1401
16. Clark RE, Xie H, Brunette MF: Benzodiazepine prescription practices and substance abuse in persons with severe mental illness. J Clin Psychiatry 2004; 65:151-155
17. Tiihonen J, Wahlbeck K, Lönnqvist J, et al: Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ 2006; 333:224
18. Tiihonen J, Lönnqvist J, Wahlbeck K, et al: 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009; 374:620-627
19. Tiihonen J, Haukka J, Taylor M, et al: A nationwide cohort study of oral and depot antipsychotics after first hospitalization for schizophrenia. Am J Psychiatry 2011; 168:603-609
20. Crump C, Winkleby MA, Sundquist K, et al: Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry 2013; 170:324-333